Signaling Pathways - KDR - FLT3 - Liver X receptors (LXRs) - Voltage-gated Calcium Channels (CaV)
清除全部
- B5953 Dovitinib (TKI258) LactateTarget: CSF-1R|FLT3|VEGFR|PDGFR|c-Kit|FGFRSummary: 酪氨酸激酶抑制剂(TKI)
- B5854 Pexidartinib (PLX3397)3 Citation中文名: 培西达替尼Target: FLT3|c-Kit|CSF1RSummary: CSF-1R抑制剂
- A8714 SR-9243Target: Liver X receptors (LXRs)Summary: LXR反相激动剂
- B5835 AZD2932Target: FLT3|VEGFR|PDGFR|c-KitSummary: VEGFR-2\PDGFRβ\Flt-3和c-Kit的抑制剂
- B5832 Altiratinib1 CitationTarget: FLT3|VEGFR|Trk Receptors|c-MET|Tie-2Summary: c-MET/TIE-2/VEGFR抑制剂
- B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂
- A8889 G-749Target: Aurora Kinases|FLT3|c-RETSummary: FLT3抑制剂
- B5351 SNX 482Target: Voltage-gated Calcium Channels (CaV)Summary: 电压依赖性R型CaV2.3钙通道阻滞剂
- B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂
- B2268 Amiloride HCl dihydrate中文名: 盐酸阿米洛利二水合物Target: Voltage-gated Sodium (NaV) Channels|Voltage-gated Calcium Channels (CaV)|UrokinasesSummary: 有效上皮钠通道(ENaC)阻断剂